癌症中的CSF-1R:不仅仅是一个髓状细胞受体
Francesca Cersosimo1, Silvia Lonardi2, Cristina Ulivieri3
1Department of Biotechnology Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
Cancers
|January 23, 2024
概括
殖民地刺激因子1受体 (CSF-1R) 在侵袭性瘤中过度表达,促进癌细胞生长和抵抗力. 用新疗法准CSF-1R可能是针对各种癌症的有希望的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 殖民地刺激因子1受体 (CSF-1R) 是一个关键的髓质受体,参与单细胞功能.
- 过度表达CSF-1R与侵略性瘤,免疫抑制和不良预后相关.
- 在瘤微环境 (TME) 中存在CSF-1R配体 (IL-34,M-CSF),这表明它在细胞交叉通话中的作用.
研究的目的:
- 审查目前有关CSF-1R表达和活性在各种癌症类型的数据.
- 为了研究CSF-1R在非骨髓癌细胞中的作用.
- 总结针对癌症中CSF-1R的治疗策略.
主要方法:
- 对癌症中CSF-1R表达和功能研究的文献综述.
- 对瘤细胞中CSF-1R信号传递数据的分析.
- 针对CSF-1R的治疗方法的概述.
主要成果:
- CSF-1R在各种固体瘤中的癌细胞上表达,而不仅仅是髓状细胞.
- CSF-1R信号传递促进癌细胞的增殖,入侵,干细胞和耐药性.
- CSF-1R信号传递可以通过癌细胞以自身隐性方式得到积极调节.
结论:
- 在癌细胞中,CSF-1R具有显著的亲瘤作用.
- 用单克隆抗体或小分子抑制剂向CSF-1R是一种有前途的治疗策略.
- 对非髓质细胞中CSF-1R的进一步研究可能会揭示新的治疗途径.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


